Antisense modulation of AKT-1 expression

{
  "publication_number": "US5958773A",
  "country": "US",
  "kind": "A",
  "title": "Antisense modulation of AKT-1 expression",
  "abstract": "Antisense compounds, compositions and methods are provided for modulating the expression of Akt-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Akt-1. Methods of using these compounds for modulation of Akt-1 expression and for treatment of diseases associated with expression of Akt-1 are provided.",
  "claims": [
    "1. An antisense compound 8 to 30 nucleotides in length targeted to a nucleic acid molecule encoding human Akt-1, wherein said antisense compound inhibits the expression of human Akt-1.",
    "2. The antisense compound of claim 1 which is an antisense oligonucleotide.",
    "3. The antisense compound of claim 2 wherein the antisense oligonucleotide has a sequence comprising SEQ ID NO: 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45 or 47.",
    "4. The antisense compound of claim 2 wherein the antisense oligonucleotide has a sequence comprising SEQ ID NO: 8, 10, 11, 14, 15, 17, 19, 20, 21, 24, 25, 26, 27, 28, 30, 31, 33, 35, 37, 38, 39, 40, 41, 43 or 44.",
    "5. The antisense compound of claim 2 wherein the antisense oligonucleotide comprises at least one modified internucleoside linkage.",
    "6. The antisense compound of claim 5 wherein the modified internucleoside linkage is a phosphorothioate linkage.",
    "7. The antisense compound of claim 2 wherein the antisense oligonucleotide comprises at least one modified sugar moiety.",
    "8. The antisense compound of claim 7 wherein the modified sugar moiety is a 2'-O-methoxyethyl sugar moiety.",
    "9. The antisense compound of claim 2 wherein the antisense oligonucleotide comprises at least one modified nucleobase.",
    "10. The antisense compound of claim 9 wherein the modified nucleobase is a 5-methylcytosine.",
    "11. The antisense compound of claim 1 wherein the antisense oligonucleotide is a chimeric oligonucleotide.",
    "12. A method of inhibiting the expression of human Akt-1 in human cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound of claim 1 so that expression of human Akt-1 is inhibited."
  ],
  "cpc": [
    "C12N 15/1137",
    "Y02P 20/582"
  ],
  "assignees": [
    "ISIS PHARMACEUTICALS INC"
  ],
  "filing_date": "1998-12-17",
  "publication_date": "1999-09-28",
  "grant_date": "1999-09-28",
  "priority_date": "1998-12-17",
  "application_number": "US-21277198-A",
  "family_id": "22792365"
}